JP2016540811A5 - - Google Patents

Download PDF

Info

Publication number
JP2016540811A5
JP2016540811A5 JP2016540686A JP2016540686A JP2016540811A5 JP 2016540811 A5 JP2016540811 A5 JP 2016540811A5 JP 2016540686 A JP2016540686 A JP 2016540686A JP 2016540686 A JP2016540686 A JP 2016540686A JP 2016540811 A5 JP2016540811 A5 JP 2016540811A5
Authority
JP
Japan
Prior art keywords
compound
phenyl
optionally substituted
oxy
acetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2016540686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016540811A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2014/066707 external-priority patent/WO2015092610A1/en
Publication of JP2016540811A publication Critical patent/JP2016540811A/ja
Publication of JP2016540811A5 publication Critical patent/JP2016540811A5/ja
Withdrawn legal-status Critical Current

Links

JP2016540686A 2013-12-20 2014-12-08 N−アシルピペリジンエーテルトロポミオシン関連キナーゼ阻害剤 Withdrawn JP2016540811A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361918783P 2013-12-20 2013-12-20
US61/918,783 2013-12-20
PCT/IB2014/066707 WO2015092610A1 (en) 2013-12-20 2014-12-08 N-acylpiperidine ether tropomyosin-related kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2016540811A JP2016540811A (ja) 2016-12-28
JP2016540811A5 true JP2016540811A5 (https=) 2017-12-28

Family

ID=52440728

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016540686A Withdrawn JP2016540811A (ja) 2013-12-20 2014-12-08 N−アシルピペリジンエーテルトロポミオシン関連キナーゼ阻害剤

Country Status (5)

Country Link
US (1) US20170305857A1 (https=)
EP (1) EP3083602A1 (https=)
JP (1) JP2016540811A (https=)
CA (1) CA2934010A1 (https=)
WO (1) WO2015092610A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016009296A1 (en) * 2014-07-16 2016-01-21 Pfizer Inc. N-acylpiperidine ether tropomyosin-related kinase inhibitors
WO2016020784A1 (en) * 2014-08-05 2016-02-11 Pfizer Inc. N-acylpyrrolidine ether tropomyosin-related kinase inhibitors
KR20190084063A (ko) 2016-10-28 2019-07-15 이칸 스쿨 오브 메디슨 엣 마운트 시나이 Ezh2-매개성 암 치료용 조성물 및 방법
EP3652165B1 (en) * 2017-07-12 2021-08-25 Bristol-Myers Squibb Company Five membered-aminoheterocyclic and 5,6-or 6,6-membered bicyclic aminoheterocyclic inhibitors of rock for the treatment of heart failure
EP3810145A4 (en) 2018-06-21 2022-06-01 Icahn School of Medicine at Mount Sinai Wd40 repeat domain protein 5 (wdr5) degradation / disruption compounds and methods of use
CA3105121A1 (en) * 2018-07-05 2020-01-09 Icahn School Of Medicine At Mount Sinai Protein tyrosine kinase 6 (ptk6) degradation / disruption compounds and methods of use
CN109970631A (zh) * 2019-03-26 2019-07-05 上海吉奉生物科技有限公司 一种5-碘-2-吡啶乙酸的合成方法
JP7503851B2 (ja) 2019-05-06 2024-06-21 アイカーン スクール オブ メディスン アット マウント シナイ Hpk1の分解剤としてのヘテロ二官能性化合物
US12103924B2 (en) 2020-06-01 2024-10-01 Icahn School Of Medicine At Mount Sinai Mitogen-activated protein kinase kinase (MEK) degradation compounds and methods of use
CN116396298A (zh) * 2023-06-06 2023-07-07 四川维亚本苑生物科技有限公司 CDK Ligand-1的中间体XII及CDK Ligand-1的制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3958002A (en) 1972-06-20 1976-05-18 Pierre Fabre S.A. Medicaments having psychotropic properties (antitussives)
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
UA80171C2 (en) 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives
CA2525207A1 (en) * 2003-06-12 2004-12-23 Novo Nordisk A/S Substituted piperidine carbamates for use as inhibitors of hormone sensitive lipase
US7417063B2 (en) 2004-04-13 2008-08-26 Bristol-Myers Squibb Company Bicyclic heterocycles useful as serine protease inhibitors
JP4842929B2 (ja) 2004-05-27 2011-12-21 ファイザー・プロダクツ・インク 癌治療に有用なピロロピリミジン誘導体
US20070275968A1 (en) 2004-09-07 2007-11-29 Hitoshi Kurata Substituted Biphenyl Derivative
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
US7405302B2 (en) 2005-10-11 2008-07-29 Amira Pharmaceuticals, Inc. 5-lipoxygenase-activating protein (FLAP) inhibitors
GB0526107D0 (en) 2005-12-22 2006-02-01 Angeletti P Ist Richerche Bio Therapeutic Compounds
RU2323058C1 (ru) 2006-07-12 2008-04-27 ООО Научно-внедренческий центр "Машины и оборудование для энергетики" Способ формирования наружной резьбы на концевом участке трубной заготовки
US20110172230A1 (en) * 2006-08-23 2011-07-14 Takahiro Ishii Urea compound or salt thereof
JP2010514695A (ja) 2006-12-21 2010-05-06 プレキシコン,インコーポレーテッド キナーゼ調節のための化合物および方法およびそのための適応症
EP1995241B1 (en) 2007-03-23 2010-03-17 ICAgen, Inc. Inhibitors of ion channels
WO2009012283A1 (en) 2007-07-17 2009-01-22 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
PE20091846A1 (es) 2008-05-19 2009-12-16 Plexxikon Inc DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
WO2009143018A2 (en) 2008-05-19 2009-11-26 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
US8110576B2 (en) 2008-06-10 2012-02-07 Plexxikon Inc. Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indications
JP5767965B2 (ja) 2008-06-10 2015-08-26 プレキシコン インコーポレーテッドPlexxikon Inc. キナーゼを調節する5h−ピロロ[2,3−b]ピラジン誘導体、およびその適応症
PE20120008A1 (es) 2009-01-12 2012-01-24 Icagen Inc Derivados de fenoxi bencenosulfonamida
KR101671046B1 (ko) 2009-04-29 2016-10-31 코와 가부시키가이샤 헤테로환 링커를 갖는 카르비놀 화합물
WO2011021645A1 (ja) * 2009-08-19 2011-02-24 大日本住友製薬株式会社 2環性ウレア誘導体、またはその薬学的に許容される塩
TWI510487B (zh) 2010-04-21 2015-12-01 Plexxikon Inc 用於激酶調節的化合物和方法及其適應症
PH12013502020A1 (en) 2011-04-05 2018-04-11 Pfizer Ltd Pyrrolo [2,3-d] pyrimidine derivatives as inhibitors of tropomyosin-related kinases
CA2835835C (en) 2011-05-13 2019-04-02 Array Biopharma Inc. Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
JP2014520879A (ja) 2011-07-15 2014-08-25 ファイザー・インク Gpr119調節因子
AU2012351748B2 (en) 2011-12-12 2016-04-14 Dr. Reddy's Laboratories Ltd. Substituted pyrazolo[1,5-a] pyridine as tropomyosin receptor kinase (Trk) inhibitors
TW201350479A (zh) 2012-04-26 2013-12-16 Ono Pharmaceutical Co Trk阻害化合物

Similar Documents

Publication Publication Date Title
JP2016540811A5 (https=)
JP2018519323A5 (https=)
JP2016535772A5 (https=)
JP2017530999A5 (https=)
JP2016516043A5 (https=)
RU2013143028A (ru) Тиазолилфенилбензолсульфонамидопроизводные в качестве ингибиторов киназ
RU2017127135A (ru) Терапевтическое средство против рака желчных протоков
JP2013545791A5 (https=)
JP2014511869A5 (https=)
JP2015524472A5 (https=)
JP2016503009A5 (https=)
JP2014528464A5 (https=)
JP2016540742A5 (https=)
JP2016513660A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
RU2017116598A (ru) Соединения и композиции для модуляции киназной активности мутантов egfr
JP2015520769A5 (https=)
JP2009534386A5 (https=)
HRP20170112T1 (hr) Supstituirani spojevi piridin-2-karboksamida kao kinazni inhibitori signalne regulacije apoptoze
JP2017537882A5 (https=)
JP2013539791A5 (https=)
RU2017116196A (ru) 2-амино-6-(дифторметил)-5,5-дифтор-6-фенил-3,4,5,6-тетрагидропиридины как ингибиторы васе1
RU2015104962A (ru) Ди- и тригетероарильные производные в качестве ингибиторов агрегации белков
JP2014516070A5 (https=)
JP2012513416A5 (https=)